Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial. Schweizer MT, True L, Gulati R, Zhao Y, et al. J Urol 2023;209:354-363.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schweizer MT, True L, Gulati R, Zhao Y, et al. Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial. J Urol 2023;209:354-363.
PMID: 36621991